Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Venus Concept Inc (VERO)

Venus Concept Inc (VERO)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 43,961
  • Shares Outstanding, K 63,999
  • Annual Sales, $ 105,620 K
  • Annual Income, $ -23,010 K
  • 60-Month Beta 2.28
  • Price/Sales 0.40
  • Price/Cash Flow N/A
  • Price/Book 1.27
Trade VERO with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.43
  • Most Recent Earnings -0.13 on 05/12/22
  • Next Earnings Date N/A
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/22
See More
  • Average Estimate -0.08
  • Number of Estimates 1
  • High Estimate -0.08
  • Low Estimate -0.08
  • Prior Year -0.04
  • Growth Rate Est. (year over year) -100.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.6200 +10.79%
on 05/24/22
1.0700 -35.80%
on 04/26/22
-0.3431 (-33.31%)
since 04/25/22
3-Month
0.6200 +10.79%
on 05/24/22
1.6900 -59.36%
on 03/01/22
-0.8931 (-56.53%)
since 02/25/22
52-Week
0.6200 +10.79%
on 05/24/22
3.3700 -79.62%
on 07/12/21
-1.3231 (-65.83%)
since 05/25/21

Most Recent Stories

More News
Venus Concept (VERO) Reports Q1 Loss, Misses Revenue Estimates

Venus Concept (VERO) delivered earnings and revenue surprises of -30% and 2.20%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

VERO : 0.6869 (+3.45%)
AXDX : 0.5486 (-5.71%)
Venus Concept Announces First Quarter of Fiscal Year 2022 Financial Results; Reaffirms Fiscal Year 2022 Revenue Guidance

TORONTO, May 12, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology...

VERO : 0.6869 (+3.45%)
Globus Medical (GMED) Misses Q1 Earnings and Revenue Estimates

Globus Medical (GMED) delivered earnings and revenue surprises of -8.70% and 1.22%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

GMED : 65.87 (+0.60%)
VERO : 0.6869 (+3.45%)
Alphatec (ATEC) Reports Q1 Loss, Tops Revenue Estimates

Alphatec (ATEC) delivered earnings and revenue surprises of -48.28% and 4.74%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

ATEC : 7.41 (+2.35%)
VERO : 0.6869 (+3.45%)
Venus Concept Receives New FDA 510(k) Clearance for Venus BlissMAX

Clearance Expands Indications for Use to Include Non-Invasive Lipolysis of the Back and Thighs and Increases Maximum Energy Output to 150 Watts...

VERO : 0.6869 (+3.45%)
Venus Concept Announces First Patient Treatment in Study Evaluating the Safety and Efficacy of Aime™ Next Generation Robotic Technology for the Treatment of Moderate to Severe Facial Wrinkles

TORONTO, April 25, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology...

VERO : 0.6869 (+3.45%)
Venus Concept to Release First Quarter of Fiscal Year 2022 Financial Results on May 12, 2022

TORONTO, April 04, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology...

VERO : 0.6869 (+3.45%)
Venus Concept Submits FDA 510(k) Related to the Use of its Aime™ Next Generation Robotic Technology for Tissue Excision and Skin Resurfacing

TORONTO, March 31, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology...

VERO : 0.6869 (+3.45%)
Venus Concept (VERO) Reports Q4 Loss, Tops Revenue Estimates

Venus Concept (VERO) delivered earnings and revenue surprises of 33.33% and 0.41%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

VERO : 0.6869 (+3.45%)
MASI : 137.81 (-2.58%)
Venus Concept Announces Fourth Quarter and Fiscal Year 2021 Financial Results; Introduces Fiscal Year 2022 Revenue Guidance

TORONTO, March 28, 2022 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology...

VERO : 0.6869 (+3.45%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Business Summary

Venus Concept Inc. designs and develops medical aesthetic equipment. The company's product portfolio consists of aesthetic device platforms, including Venus Versa(TM), Venus Legacy(TM), Venus Velocity(TM), Venus Fiore(TM), Venus Viva(TM), Venus Freeze Plus(TM) and Venus Bliss(TM). It also provides NeoGraft(R),...

See More

Key Turning Points

3rd Resistance Point 0.7973
2nd Resistance Point 0.7525
1st Resistance Point 0.7197
Last Price 0.6869
1st Support Level 0.6421
2nd Support Level 0.5973
3rd Support Level 0.5645

See More

52-Week High 3.3700
Fibonacci 61.8% 2.3195
Fibonacci 50% 1.9950
Fibonacci 38.2% 1.6705
Last Price 0.6869
52-Week Low 0.6200

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar